Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO Subscriptions PDA Services My JCO Customer Service

Journal of Clinical Oncology, Vol 25, No 2 (January 10), 2007: pp. 217-222
© 2007 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.08.0481

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sulmasy, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sulmasy, D. P.

REVIEW ARTICLE

Cancer Care, Money, and the Value of Life: Whose Justice? Which Rationality?

Daniel P. Sulmasy

From the St Vincent's Hospital—Manhattan and New York Medical College, New York, NY

Address reprint requests to Daniel P. Sulmasy, OFM, MD, PhD, The John J. Conley Department of Ethics, St Vincent's Hospital—Manhattan, 153 W 11th St, New York, NY 10011; e-mail: daniel_sulmasy{at}nymc.edu

Cost-containment in oncology is a moral issue. While economists use the word "rationing" to describe all limitations on resource utilization that result from human choice, the ordinary language distinction between allocation and rationing is morally meaningful and can help oncologists to determine their proper moral role in cost-containment. It is argued that oncologists should not be required to ration at the bedside, nor should they be given financial incentives to practice frugally, nor should they be subjected to a variety of bureaucratic mechanisms to control costs indirectly. In addition, it is argued that the fact that treatments have a price does not logically imply that patients have a price. Cost-effectiveness analysis is often suggested as a means of deciding how best to allocate resources, but some of its many ethical limitations are discussed. The alternative is an open, public, participatory process about how to ration care, abandoning the formulaic pretenses of cost-effectiveness analysis, but with a commitment to reason, good will, and common sense. Oncologists would then be free to advocate for their patients within the constraints imposed by this public process.

Author's disclosures of potential conflicts of interest and author contributions are found at the end of this article.




This article has been cited by other articles:


Home page
Ann OncolHome page
A Bernardi, A Jirillo, R Pegoraro, and M. Bonavina
Allocation of public sources in oncology: which role can ethics play?
Ann. Onc., July 1, 2007; 18(7): 1129 - 1131.
[Full Text] [PDF]


Home page
JCOHome page
N. J. Meropol and K. A. Schulman
Perspectives on the Cost of Cancer Care
J. Clin. Oncol., January 10, 2007; 25(2): 169 - 170.
[Full Text] [PDF]


Home page
JCOHome page
N. J. Meropol and K. A. Schulman
Cost of Cancer Care: Issues and Implications
J. Clin. Oncol., January 10, 2007; 25(2): 180 - 186.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 Site Map

Copyright © 2007 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online